Bioinformatics Market by Application (Genomics, Molecular Phylogenetics, Metabolomics, Proteomics, Chemoinformatics and Drug Designing) to Reach USD 12.48 Billion by 2020
San Francisco, California (PRWEB) April 08, 2014 -- The global market for bioinformatics is expected to reach USD 12.48 billion by 2020, according to a new study by Grand View Research, Inc. Rapidly declining prices of DNA sequencing, growing adoption rates of bioinformatics as a cost effective tool for database management during clinical trials, increasing government initiatives encouraging the use of bioinformatics in drug discovery and the use of bioinformatics tools in emerging fields such as chemogenomics are some of the factors expected to drive market growth over the next six years. In addition, the introduction of advance technologies such as nanopore and cloud computing are expected to serve this market as future growth opportunities.
The report “Bioinformatics Market Analysis And Segment Forecasts To 2020,” is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/bioinformatics-industry.
Inquiry before buying at http://www.grandviewresearch.com/inquiry/10.
Bioinformatics platform products are expected to dominate the market, along with being the fastest growing segment, at an estimated CAGR of 22.8% from 2014 to 2020. The increasing demand for these platforms in technologically advanced processes such as high throughput screening for combination therapies namely pharmacogenomics and pharmacoproteomics is expected to serve this market as drivers during the forecast period. Global biocontent product demand is expected to reach USD 4.30 billion by 2020, growing at a CAGR of 16.9% from 2014 to 2020.
Further key findings from the study suggest:
• Bioinformatics based metabolomics applications are expected to grow at the highest CAGR of over 23.0% from 2014 to 2020 owing to the introduction of new analytical instruments proving vital for high throughput and accuracy enabled metabolite profiling.
• North America was the largest regional market in 2013, accounting for over 42% of global revenue. The presence of sophisticated healthcare infrastructure enabling advance R&D exercises, high availability of government funding and the high volume of pre-clinical studies conducted in this region are some of the factors expected to drive market growth.
• Asia Pacific bioinformatics market is expected to grow at the highest CAGR of 25.9% from 2014 to 2020 on account of rising demand for CRO (Contract Research Outsourcing) initiatives as a result of high cheap labor availability and rapidly improving healthcare infrastructure in emerging markets such as India and China.
• Key industry participants include IBM Life Sciences, Agilent Technologies, Affymetrix, Life Technologies Corporation, 3rd Millennium Inc., Celera Corporation, Accelrys Inc. and others.
Request sample of this report at http://www.grandviewresearch.com/request/10.
For the purpose of this study, Grand View Research has segmented the global bioinformatics market on the basis of product, application and region:
• Bioinformatics Product Outlook
• Bioinformatics Platforms
• Sequence Analysis Platforms
• Sequence Manipulation Platforms
• Sequence Alignment Platforms
• Structural and Functional Analysis Platforms
• Others
• Bioinformatics Services
• Database Management
• Sequencing
• Data Analysis
• Others
• Biocontent
• Generalized Biocontent
• Specialized Biocontent
• Bioinformatics Application Outlook
• Genomics
• Molecular Phylogenetics
• Metabolomics
• Proteomics
• Transcriptomics
• Chemoinformatics and Drug Designing
• Others
• Bioinformatics Regional Outlook
• North America
• Europe
• Asia Pacific
• RoW
Browse all Healthcare IT market reports at http://www.grandviewresearch.com/industry/healthcare-it.
Latest Reports Published By Grand View Research:
Bring Your Own Device (BYOD) Market Analysis And Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/bring-your-own-device-market) The global market for bioinformatics is expected to reach USD 12.48 billion by 2020, according to a new study by Grand View Research, Inc. Rapidly declining prices of DNA sequencing, growing adoption rates of bioinformatics as a cost effective tool for database management during clinical trials, increasing government initiatives encouraging the use of bioinformatics in drug discovery and the use of bioinformatics tools in emerging fields such as chemogenomics are some of the factors expected to drive market growth over the next six years.
Bitumen Market Analysis And Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/bitumen-market) The global market for bitumen is expected to reach USD 95.77 billion by 2020, according to a new study by Grand View Research, Inc. Bitumen is primarily used in road construction activities and increased road development in high growth markets of India, China and Brazil is expected to be a key driver for the growth of the market.Roadway constructions were the major consumers of bitumen in 2013, accounting for over 80 million tons of global consumption. Other key applications include waterproofing, insulation and adhesives.
About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Sherry James, Grand View Research, Inc., http://www.grandviewresearch.com/, +1 4153490058, [email protected]
Share this article